Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Baricitinib

Product Specifications

Background

Baricitinib is a selective orally bioavailable JAK1/JAK2 inhibitor with nanomolar potency against JAK1 (IC50 = 5.9nM) and JAK2 (IC50 = 5.7nM) and inhibits Tyk2 (IC50 = 53nM) . It displays >100-fold selectivity for JAK1/2 over JAK3 (IC50 > 400nM) . Janus kinases (JAKs) are non-receptor kinases and play important roles in the proinflammatory signaling pathways that are frequently over-activated in autoimmune disorders such as rheumatoid arthritis. Upon binding of extracellular cytokines and growth factors, JAKs are phosphorylated and activate signal transducers and activators of transcription (STATs) . Via these signaling cascades, inflammatory cytokine and chemokine transcription is induced to form inflammatory mediators including IL-2, IL-6, IL-12, IL-15, IL-23. Baricitinib inhibits intracellular signaling of multiple proinflammatory cytokines including IL-6 and IL-23 at concentrations <50nM. It inhibits IL-6 receptor signaling, IL-6-induced STAT phosphorylation and subsequent pro-inflammatory chemokine (MPC-1) and cytokine (IL-17 and IL-22) production in PBMCs and T cells and displays anti-inflammatory and disease modifying effects in the rat adjuvant arthritis model. It also has been shown to block MSU-induced inflammasome activation. Baricitinib has potential application in various inflammatory disorders, including rheumatoid arthritis and systemic lupus erythematosus (SLE) . The majority of viruses enter cells through receptor mediated endocytosis. Baricitinib potently inhibits AP-2 associated protein kinase 1 (AAK1) and also binds cyclin G-associated kinase, both regulators of endocytosis. Inhibiting AAK1 might interrupt the passage of the SARS-CoV-2 virus into cells and also the intracellular assembly of virus particles. In addition the drug’s anti-inflammatory activity is expected to act on the inflammatory cascade associated with COVID-19.

CAS Number

1187594-09-7

Type

Chemical

Purity

Greater than or equal to 98% (HPLC)

Shipping Conditions

Room Temp

Storage Conditions

Short Term Storage: +4C. Long Term Storage: -20C. Handling Advice: Keep cool and dry. Use/Stability: Stable for at least 2 years after receipt when stored at -20C.

Calculated Molecular Weight

371.4

Other Product Names

LY3009104; INCB28050; 1- (Ethylsulfonyl) -3-[4- (7H-pyrrolo[2,3-d]pyrimidin-4-yl) -1H-pyrazol-1-yl]-3-azetidineacetonitrile

Physical Properties

Lyophilized

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human Bronchial Fibroblast Medium
ARM0147 500 mL

Human Bronchial Fibroblast Medium

Sign In for Pricing
View Details
PRRSV NP/Nucleoprotein Antibody
orb3152334-01 50 µg

PRRSV NP/Nucleoprotein Antibody

Sign In for Pricing
View Details
PRRSV NP/Nucleoprotein Antibody
orb3152334-02 100 µg

PRRSV NP/Nucleoprotein Antibody

Sign In for Pricing
View Details
PRRSV NP/Nucleoprotein Antibody
orb3152334-03 1 mg

PRRSV NP/Nucleoprotein Antibody

Sign In for Pricing
View Details
GDF-15 Recombinant Protein Antigen
NBP2-52917PEP 0.1 mL

GDF-15 Recombinant Protein Antigen

Sign In for Pricing
View Details
Canine Anti mitochondrial antibodies ELISA kit
GTR10408673 96 Well

Canine Anti mitochondrial antibodies ELISA kit

Sign In for Pricing
View Details